FUSION PHARMACEUTICALS INC.
Live / Registered — Registered (as of 25 Jul 2023)
What this means for you
Registered since 25 Jul 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 90667641
- Registration number
- 7122419
- Mark type
- Design + words
- Filed
- 23 Apr 2021
- Published for opposition
- 31 May 2022
- Registered
- 25 Jul 2023
- Attorney of record
- Jonathan M. Gelchinsky
Goods and services
- Class 005 — Pharmaceuticals: Biopharmaceuticals for the treatment of cancer and other diseases consisting of proteins linked to therapeutic isotopes which deliver a cytotoxic payload to affected cells, including but not limited to cancer cells; radio-isotope markers and antibodies for medical diagnostic and therapeutic use
Owner
- Fusion Pharmaceuticals Inc., Hamilton, Ontario, CA
- Fusion Pharmaceuticals Inc., Hamilton, Ontario, CA
- Fusion Pharmaceuticals Inc., Hamilton, Ontario, CA
Prosecution history
- 25 Jul 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 25 Jul 2023 — REGISTERED-PRINCIPAL REGISTER
- 23 Jun 2023 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 22 Jun 2023 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 06 Jun 2023 — STATEMENT OF USE PROCESSING COMPLETE
- 15 May 2023 — USE AMENDMENT FILED
- 06 Jun 2023 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 15 May 2023 — TEAS STATEMENT OF USE RECEIVED
- 04 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 02 May 2023 — SOU EXTENSION 1 GRANTED
- 02 May 2023 — SOU EXTENSION 1 FILED
- 02 May 2023 — SOU TEAS EXTENSION RECEIVED
- 29 Nov 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Oct 2022 — NEW NOA TO ISSUE
- 26 Jul 2022 — NOTICE OF ALLOWANCE CANCELLED